Literature DB >> 6200329

Effects of sodium butyrate and dimethylsulfoxide on human pancreatic tumor cell lines.

L J McIntyre, Y S Kim.   

Abstract

The effects of 1 mM sodium butyrate or 2% dimethylsulfoxide (DMSO) on three human pancreatic tumor cell lines were examined. The cell lines tested were MIA PaCa-2, PANC-1 and CAPAN-1. Both butyrate and DMSO inhibited the ability of all three lines to form colonies in soft agar. These results suggest that the use of these agents provides a model system for the study of the molecular changes involved in human pancreatic cancer. In butyrate all the cell lines showed a marked increase in cellular levels of alkaline phosphatase, while growth in DMSO led to a reduction in most cases. DMSO caused a rapid reduction in the attachment of all three cell lines to collagen substrates, while butyrate had no effect. These results illustrate the fact that although both butyrate and DMSO appear to greatly reduce the parameters correlated with tumorigenicity of human pancreatic cancer cells, the mechanisms involved may be very different.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6200329     DOI: 10.1016/0277-5379(84)90194-9

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  11 in total

Review 1.  Current evidence for histone deacetylase inhibitors in pancreatic cancer.

Authors:  Ioannis Koutsounas; Constantinos Giaginis; Efstratios Patsouris; Stamatios Theocharis
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

2.  Induction of haem synthesis in Hep G2 human hepatoma cells by dimethyl sulphoxide. A transcriptionally activated event.

Authors:  R A Galbraith; S Sassa; A Kappas
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

3.  Butyric acid: inhibition of non-leukemic and chronic myeloid leukemia granulocyte macrophage clonal growth.

Authors:  E Januszewicz; E Rabizadah; A Novogrodsky; M Shaklai
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

4.  Differentiation of pancreatic carcinoma induced by retinoic acid or sodium butyrate: a morphological and molecular analysis of four cell lines.

Authors:  N Egawa; B Maillet; B VanDamme; J De Grève; G Klöppel
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

5.  Modulation of enzymatic activities during spontaneous and induced differentiation in a human pancreatic adenocarcinoma cell line CAPAN-1.

Authors:  N Bensaadi; F Clemente; N Vaysse
Journal:  Int J Pancreatol       Date:  1989-05

Review 6.  Phenotype and genotype of pancreatic cancer cell lines.

Authors:  Emily L Deer; Jessica González-Hernández; Jill D Coursen; Jill E Shea; Josephat Ngatia; Courtney L Scaife; Matthew A Firpo; Sean J Mulvihill
Journal:  Pancreas       Date:  2010-05       Impact factor: 3.327

7.  Trypsinogen expression by two human pancreatic cell lines CFPAC-1 and CAPAN-1. Modulation during spontaneous and induced cell growth.

Authors:  B Miszczuk-Jamska; M Merten; W Renaud; O Guy-Crotte; C Figarella
Journal:  Int J Pancreatol       Date:  1994-08

8.  Mechanism-based mathematical modeling of combined gemcitabine and birinapant in pancreatic cancer cells.

Authors:  Xu Zhu; Robert M Straubinger; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-08-08       Impact factor: 2.745

9.  Cyclic-AMP-stimulated synthesis and release of carcinoembryonic antigen by pancreatic cancer cells.

Authors:  T L Sack; J R Gum; Y S Kim
Journal:  Int J Pancreatol       Date:  1988-03

10.  The small heat shock protein αA-crystallin negatively regulates pancreatic tumorigenesis.

Authors:  Jifang Liu; Zhongwen Luo; Lan Zhang; Ling Wang; Qian Nie; Zheng-Feng Wang; Zhaoxia Huang; Xiaohui Hu; Lili Gong; Andre-Patrick Arrigo; Xiangcheng Tang; Jia-Wen Xiang; Fangyuan Liu; Mi Deng; Weike Ji; Wenfeng Hu; Ji-Ye Zhu; Baojiang Chen; Julia Bridge; Michael A Hollingsworth; James Gigantelli; Yizhi Liu; Quan D Nguyen; David Wan-Cheng Li
Journal:  Oncotarget       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.